C

Compass Pathways

Develops psilocybin-based therapies for TRD

Manager – Supply Chain

Supply Chain ManagementPosted on Nov 6
Full-time

About the Job

Requirements

  • Bachelor’s degree or equivalent in a science, operations management, or closely related subject, or relevant industry experience.
  • Prior experience working in a biotech or pharmaceutical company.
  • Proven stakeholder management experience.
  • Working knowledge of Good Manufacturing Practice, Good Clinical Practice, and Good Distribution Practice.
  • Project planning and risk management skills.
  • Ability to react to changing priorities and multitask.
  • Understanding of clinical trial procedures and knowledge of commercial supply chain.

Responsibilities

  • Ensure processes and systems effectively manage manufacturing and supply chain operations for clinical trial and commercial materials.
  • Oversee timely delivery of bulk drug product to distribution partners and ensure packaging, labeling, release, and shipping meet project timelines.
  • Collaborate with clinical and commercial regulatory partners and distribution vendors to secure approvals needed to meet shipping deadlines.
  • Manage drug product shelf life and arrange resupply to ensure continuity of supply to clinical study sites.
  • Contribute to revisions of the Investigational Medicinal Product Dossier as needed.
  • Manage and establish collaborations with worldwide vendors selected for the clinical and commercial supply chain, in line with regulatory requirements.
  • Build and maintain relationships with key manufacturing and packaging partners.
  • Conduct project management activities, including critical path planning, resource planning, and budgeting.
  • Identify risks, implement mitigations and controls, and monitor and report status.

Desired Qualifications

  • Commercial supply chain project management experience.

About the Company

Compass Pathways

Develops psilocybin-based therapies for TRD

COMPASS Pathways develops psilocybin-based therapies for mental health, focusing on treating treatment-resistant depression (TRD). Its lead drug candidate, COMP360, is a high-purity psilocybin formulation given alongside psychological support from trained therapists. The treatment is delivered through a global Phase 3 program, aiming to establish a regulatory-approved therapy. Compared with other players, COMPASS emphasizes a standardized therapeutic model that pairs a pharmaceutical compound with guided psychotherapy and has the largest psilocybin Phase 3 program to date, supported by Breakthrough Therapy designation from the FDA. The company originated from a nonprofit idea, transformed into a for-profit entity to fund extensive trials, and is pursuing regulatory approval and eventual commercialization through licensing and partnerships. Its goal is to bring approved, evidence-based psilocybin treatments to patients with TRD and scale access through a commercial pathway.

Company size
201-500
Company stage
IPO
Headquarters
London, United Kingdom
Founded
2016

Recently Posted Jobs

Explore more opportunities at Compass Pathways

See more jobs